Table 3. ORs between Group 2 (HPV negative without cervical cancer) and Group 3 (HPV negative without cervical cancer).
Genotype | Group 2 (n = 225) | Group 3 (n = 318) | OR* (95% CI) | P | OR* (95% CI) | P |
No. (%) | No. (%) | |||||
GG | 188 (83.6) | 274 (86.2) | Reference | 1.540(0.599–3.960) | 0.371 | |
GA | 28 (12.4) | 35 (11.0) | 0.880(0.516–1.502) | 0.640 | 1.356(0.473–3.889) | 0.571 |
AA | 9 (4.0) | 9 (2.8) | 0.649(0.253–1.670) | 0.371 | reference | |
GG+GA | 216 (96.0) | 309 (97.2) | Reference | 1.517 (0.591–3.893) | 0.386 | |
AA | 9 (4.0) | 9 (2.8) | 0.659(0.257–1.692) | 0.386 | reference | |
GA+AA | 37 (16.4) | 44 (13.8) | Reference | 0.822 (0.510–1.325) | 0.421 | |
GG | 188 (83.6) | 274 (86.2) | 1.216(0.755–1.961) | 0.421 | reference |
Note: * Data were calculated by multivariate regression analysis, adjusting for age and smoking status.